Cite

HARVARD Citation

    Joerger, M. et al. (n.d.). 1056PDPhase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression. Annals of oncology. p. . [Online]. 
  
Back to record